Literature DB >> 31807499

Nanotechnology as a savior in asthma management.

Chin Kook Rhee1.   

Abstract

Entities:  

Year:  2019        PMID： 31807499      PMCID： PMC6861766          DOI： 10.21037/atm.2019.09.98

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  9 in total

1.  Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma.

Authors:  William W Busse; Stephen Holgate; Edward Kerwin; Yun Chon; Jingyuan Feng; Joseph Lin; Shao-Lee Lin
Journal:  Am J Respir Crit Care Med       Date:  2013-12-01       Impact factor: 21.405

2.  Association between Inhaled Corticosteroid Use and Pulmonary Nontuberculous Mycobacterial Infection.

Authors:  Vincent X Liu; Kevin L Winthrop; Yun Lu; Husham Sharifi; Hekmat U Nasiri; Stephen J Ruoss
Journal:  Ann Am Thorac Soc       Date:  2018-10

Review 3.  Advances in nanotechnology and asthma.

Authors:  Lingwei Wang; Mengjie Feng; Qiuwen Li; Chen Qiu; Rongchang Chen
Journal:  Ann Transl Med       Date:  2019-04

4.  Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.

Authors:  Tobias W M Keil; Daniel P Feldmann; Gabriella Costabile; Qian Zhong; Sandro da Rocha; Olivia M Merkel
Journal:  Eur J Pharm Biopharm       Date:  2019-08-21       Impact factor: 5.571

Review 5.  Nanotechnology based therapeutics for lung disease.

Authors:  Mohammad Doroudian; Ronan MacLoughlin; Fergus Poynton; Adriele Prina-Mello; Seamas C Donnelly
Journal:  Thorax       Date:  2019-07-08       Impact factor: 9.139

6.  Use of inhaled corticosteroids and the risk of tuberculosis.

Authors:  Chang-Hoon Lee; Kyungjoo Kim; Min Kyung Hyun; Eun Jin Jang; Na Rae Lee; Jae-Joon Yim
Journal:  Thorax       Date:  2013-06-08       Impact factor: 9.139

7.  Inflammatory Asthma Phenotype Discrimination Using an Electronic Nose Breath Analyzer.

Authors:  V Plaza; A Crespo; J Giner; J L Merino; D Ramos-Barbón; E F Mateus; A Torrego; B G Cosio; A Agustí; O Sibila
Journal:  J Investig Allergol Clin Immunol       Date:  2015       Impact factor: 4.333

8.  Treatable traits: toward precision medicine of chronic airway diseases.

Authors:  Alvar Agusti; Elisabeth Bel; Mike Thomas; Claus Vogelmeier; Guy Brusselle; Stephen Holgate; Marc Humbert; Paul Jones; Peter G Gibson; Jørgen Vestbo; Richard Beasley; Ian D Pavord
Journal:  Eur Respir J       Date:  2016-02       Impact factor: 16.671

Review 9.  Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease.

Authors:  Lydia Finney; Matthew Berry; Aran Singanayagam; Sarah L Elkin; Sebastian L Johnston; Patrick Mallia
Journal:  Lancet Respir Med       Date:  2014-09-17       Impact factor: 30.700
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.